Funding for COVID-19 Research – Updated 6/25/20
General Funding Resources
- COVID-19/Coronavirus Resources (updated continually)
- Spin Global Suite
Federal Funding
National Institutes of Health (NIH)
- Rapid Acceleration of Diagnostics RADx-UP Webinars (June 23)
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding (continually updated)
- NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing (May 1)(Rolling basis)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) (March 10)
- Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) (February 6) (Rolling basis)
- Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) (March 11)
- Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) (September 9)
- Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) (Continuous Submission)
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (May 13)
- Search the NIH Funding Database for more “COVID-19” research funding opportunities.
National Science Foundation (NSF)
- Coronavirus Information (continually updated)
- Dear Colleague Letter: Supporting Research on Pandemics within the Civic Innovation Challenge and Broadened NSF Support for the Challenge (June 22)
- Civic Innovation Challenge (CIVIC) Program (July 1)--NSF expects to add sub-tracks related to COVID-19 to the existing Communities and Mobility and Resilience to Natural Disasters tracks of the Civic Innovation Challenge (CIVIC) program
- Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter (DCL) on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) (June 2)
- Cyber-Physical Systems (CPS) (Submission window: June 8-22)
- NSF-BSF Joint Funding Research Grants (continually updated)
Dear Colleague Letter: Research Experiences for Undergraduates Supplemental Funding in Computer and Information Science and Engineering (April 28) - Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) (March 5) (Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed.)
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (April 3)
- Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) (March 17)
Department of Defense (DOD)
- CSO_COVID_19 Response (Due September 30)
- COVID-19 Seedling Research Topics (due July 7)
- Ventilator Challenge Call for Proposals (May 11)
- Wearable Diagnostic for Detection of COVID-19 Infection (Closes May 13)
- Perform COVID-19 Modeling and Prediction Analyses (Due May 4)
- Air Force Acquisition COVID-19 Task Force (DAF ACT) (closes September 30)
- National Emergency Telecritical Care Network (NETCCN) Project for Coronavirus (April 27--White Papers due)
- National Emergency Telecritical Care Network (NETCCN) Project for Coronavirus (closes April 30)
- Prototype Development to Combat Novel Coronavirus Disease COVID-19 (April 15)
- Army Futures Command--Army Applications Laboratory--COVID-19 Response Innovations (April 13)--If interested, please reach out to the Research Development & Support (RDS) team at rds@vanderbilt.edu.
- Navy SBIR Broad Agency Announcement (May 28 Proposals Due)
- CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health (closes June 12)
- CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health (closes June 12)
- Peer Reviewed Medical Research Program (PRMRP) open to Emerging Viral Diseases and Respiratory Health with a focus on COVID-19 (Pre-app. deadline June 8)
- MTEC-20-09-COVID-19_Treatment_MIDRP “Development of Treatments for COVID-19” (April 8)
- xTech COVID-19 Ventilator Challenge (Submit by April 13)
- High Performance Computing, Modeling, and Simulation Projects (Concept Papers due April 30)
- Newton Award for Transformative Ideas during the COVID-19 Pandemic (April 3)
- Joint Acquisition Task Force (JATF) (April 3)
- Small Business Innovation Research (SBIR) Program X20.R SBIR Commercial Solutions Opening (CSO) AF Ventures Direct to Phase II (March 30)
- Request for Information for PPE in response to COVID-19 (March 24)
- (Intent and Direction) Engaging the Research and Development Industrial Base during COVID-19 (March 24)
Department of Energy (DOE)
- Oak Ridge National Laboratory: Rapid Access for COVID-19 Research
- National Virtual Biotechnology Laboratory (NVBL) (April 28)
- COVID-19 HPC Consortium (April 1)
- DOE Seeking Input and Collaboration on Science and Technology Response to COVID-19 (several opportunities and closing dates)
- Dear Colleague Letter (March 12)
- The COVID-19 High Performance Computing Consortium (March 22)
All Other Federal Funding
For a comprehensive, continually updated list of funding opportunities provided by NIH subsidiary institutes, please visit the funding section of Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding.
Agency for Healthcare Research and Quality
- Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) (due May 29)
- Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) (due June 1)
- Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) (May 1)
- Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) (May 1)
- Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (March 26)
- Army Futures Command--Army Applications Laboratory--COVID-19 Response Innovations (April 13)--If interested, please reach out to the Research Development & Support (RDS) team at rds@vanderbilt.edu.
Biomedical Advanced Research and Development Authority (BARDA)
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement (Rolling)
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) (April 30)
- The solicitation notes that “the diagnostics must utilize platforms already cleared by the U.S. Food and Drug Administration, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of an award.
Center for Disease Control and Prevention (CDC)
- Information for CDC Applicants and Recipients of CDC Funding (continually updated: funding opportunities and guidance)
- Centers for Disease Control COVID-19 Broad Agency Announcement (March 25)
- Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health (March 20)
Defense Logistics Agency (DLA)
- DLA’s Technology Accelerator OTA Program (Closes May 4)
- Addressing Pandemic Propaganda and Disinformation in Africa (June 23)
- DRL FY19 Countering Corruption amid COVID-19 (closes June 12)
- COVID-19 Small Grants Program (September 30)
- U.S. Embassy Abuja COVID19 Response (May 1 closure)
Medical CBRN Defense Consortium (MCDC)
- CoV Pandemic Response (March 19 - May 31)
National Center for Advancing Translational Sciences (NCATS)
- Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (March 27)
- Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need (March 24)
National Human Genome Research Institute (NHGRI)
- Notice of NHGRI’s Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" (March 31)
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 31)
National Institute of Allergy and Infectious Disease (NIAID)
- NIAID Strategic Plan for COVID-19 Research (April 23)
- Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (March 27)
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (March 13)
- Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) (March 11)
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (February 6)
- NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak (February 19)
- 2020 NIAID Omnibus Broad Agency Announcement (April 9)
National Institute on Drug Abuse (NIDA)
- Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 19) (supplement to existing awards)
National Institute for Health Research (NIHR)
- Travel and Subsistence Funding to Support LMIC Engagement During the COVID-19 Outbreak - Applicant Guidance (May 30) (continuous submission)
All Other Funding
Please visit the Office of Corporate and Foundation Relations for additional COVID-19 funding opportunities.
Coalition for Epidemic Preparedness Innovations (CEPI)
- CEPI launches new funding opportunity to accelerate COVID-19 vaccine development and production (rolling basis until at least June 30)
- Call for ideas for EdTech responses to coronavirus (COVID-19) (May 25--cut off for final round)
National Multiple Sclerosis Society
- Society Funding with message on COVID-19 impact to funding (June 25)
Natural Environment Research Council
- Urgency grants (no closing date)
U.S-Israel Binational Science Foundation
- NSF-BSF Joint Funding Research Grants (continually updated)
- Call for Proposals in Joint NSF-BSF Programs Dealing with the Coronavirus Disease (no closing date)
- COVID-19 HPC Consortium (April 3)